|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$81,660,525 |
|
|
Indirect Value
|
$12,932,114,466 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,013,774,992 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 26 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$1,491,922 |
I/I |
55,183 |
5,729,287 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$919 |
I/I |
34 |
194,218 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-27 |
4 |
B |
$27.04 |
$39,581 |
I/I |
1,464 |
154,104 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$1,512,235 |
I/I |
55,039 |
5,784,326 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$934 |
I/I |
34 |
194,252 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-05-31 |
4 |
B |
$27.46 |
$40,142 |
I/I |
1,461 |
155,565 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,964,575 |
I/I |
71,471 |
5,855,797 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$1,209 |
I/I |
44 |
194,296 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-01 |
4 |
B |
$27.47 |
$46,894 |
I/I |
1,706 |
157,271 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-07 |
4 |
B |
$26.14 |
$43,214 |
I/I |
1,652 |
158,923 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-07 |
4 |
B |
$26.14 |
$1,810,136 |
I/I |
69,198 |
5,924,995 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-07 |
4 |
B |
$26.14 |
$1,125 |
I/I |
43 |
194,339 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-08 |
4 |
B |
$26.10 |
$27,828 |
I/I |
1,065 |
159,988 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-08 |
4 |
B |
$26.10 |
$1,164,432 |
I/I |
44,563 |
5,969,558 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-08 |
4 |
B |
$26.10 |
$706 |
I/I |
27 |
194,366 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-09 |
4 |
B |
$26.25 |
$2,360,109 |
I/I |
89,891 |
6,059,449 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-09 |
4 |
B |
$26.25 |
$1,286 |
I/I |
49 |
194,415 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-09 |
4 |
B |
$26.25 |
$43,873 |
I/I |
1,671 |
161,659 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(7,280) |
187,135 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
7,280 |
6,066,729 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$21,986 |
I/I |
898 |
162,557 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$2,938 |
I/I |
120 |
1,253,773 |
2.17 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-03 |
4 |
B |
$24.42 |
$519,553 |
I/I |
21,221 |
6,087,950 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-04 |
4 |
B |
$25.78 |
$1,441,461 |
I/I |
55,920 |
6,143,870 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2011-11-04 |
4 |
B |
$25.78 |
$60,963 |
I/I |
2,365 |
164,922 |
2.25 |
- |
|
1397 Records found
|
|
Page 26 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|